Al Kubaisi K A, SteCroix M D, Vinson D, Hassan M N, Baig M R, Sharif S L, Abduelkarem A R
University of Gloucestershire, The Park, Cheltenham, GL50 2RH, United Kingdom.
University of Worcester, Saint-John's Campus, Henwick Grove, Worcester, WR2 6AJ, United Kingdom.
Ann Pharm Fr. 2018 Sep;76(5):348-354. doi: 10.1016/j.pharma.2018.03.008. Epub 2018 Apr 26.
Use of overdosage of Non-Prescription Drugs (NPD) among university students is a serious public health issue. However, there are no extensive studies that measured the prevalence of taking more than the recommended dose of NPD and/or identified the risk associated with this behavior among university students.
This study was undertaken to assess the prevalence and associated risks of self-overdosage with NPDs in university students in United Arab Emirates (UAE).
A cross-sectional survey-based study was conducted from January to April 2014, among 2875 students in three randomly selected universities. A structured and validated questionnaire was used to collect the responses of the students. SPSS version 20 was used to analyze the data.
Out of 2875 students, only 2355 surveys were fully answered, returned back and included in the present study. Of 2355, more than half (1348; 57.2%) the participants reported using Oral NPD (ONPD) in the past 90 days before conducting the study and were asked to complete the survey. Only 290 (22%) of a total 1348 participants reported taking more than the recommended dose of ONPD in the previous three months before conducting the study. Analgesic/antipyretic (223, 16.5%) and anti-allergic (67, 4.9%) drugs were more than other classes of the ONPD, reported to be taken in a dose, more than the recommended dosage. The most common justifications for taking more than the recommended dose of ONPD among respondents were severe symptoms (6%), the belief that the recommended dose would not be sufficient to relieve the symptom (5%), the belief that a stronger dose would relieve the symptoms faster (11%), and previous experience (4%). Our results identified three risk factors for taking more than the recommended dose of NPD. High frequently drug-users of daily use (OR=3.494, 95% CI: 1.677-7.279) (P<0.001), and students from non-medical colleges had higher odds of taking more than the recommended dosage as compared to students from medical colleges (OR=1.486, 95% CI: 1.060-2.085, P-value<0.05). Furthermore\re, participants with a poly-pharmacy behavior had higher odds of taking overdosage of ONPD than single NPD users (OR=1.918, 95% CI: 1.440-2.555) (P<0.001).
There are a sizable proportion of university students that use overdosage of NPD, but it is more serious issue when it comes to non-medical student. There is a need for educational programs designed to increase awareness among all university students and to motivate them not to use overdosage of NPD. Further studies are also required to investigate additional explanatory variables that could influence the practice of overdosage with NPD.
大学生过量使用非处方药是一个严重的公共卫生问题。然而,尚无广泛研究测量服用超过推荐剂量的非处方药的流行情况,和/或确定大学生中这种行为相关的风险。
本研究旨在评估阿联酋大学生自我过量服用非处方药的流行情况及相关风险。
2014年1月至4月,在三所随机选取的大学中对2875名学生开展了一项基于横断面调查的研究。采用一份结构化且经过验证的问卷收集学生的回答。使用SPSS 20版分析数据。
在2875名学生中,只有2355份调查问卷得到完整回答、返回并纳入本研究。在这2355名学生中,超过半数(1348名;57.2%)的参与者报告在开展本研究前的过去90天内使用过口服非处方药(ONPD),并被要求完成调查。在总共1348名参与者中,只有290名(22%)报告在开展本研究前的前三个月内服用超过推荐剂量的ONPD。据报告,镇痛/解热药(223名,16.5%)和抗过敏药(67名,4.9%)比其他类别的ONPD更多地被报告以超过推荐剂量服用。在受访者中,服用超过推荐剂量ONPD的最常见理由是症状严重(6%)、认为推荐剂量不足以缓解症状(5%)、认为更强剂量能更快缓解症状(11%)以及既往经验(4%)。我们的结果确定了服用超过推荐剂量非处方药的三个风险因素。日常频繁用药者(比值比=3.494,95%置信区间:1.677 - 7.279)(P<0.001),并且与医学院学生相比,非医学院学生服用超过推荐剂量的几率更高(比值比=1.486,95%置信区间:1.060 - 2.085,P值<0.05)。此外,有联合用药行为的参与者服用过量ONPD的几率高于单一使用非处方药的使用者(比值比=1.918,95%置信区间:1.440 - 2.555)(P<0.001)。
有相当比例的大学生过量使用非处方药,但对于非医学专业学生而言,这是一个更严重的问题。需要设计教育项目以提高所有大学生的认识,并激励他们不要过量使用非处方药。还需要进一步研究调查可能影响非处方药过量使用行为的其他解释变量。